Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2024 Filed Jun 3, 2024 16:16 UTC |
SATO VICKI LDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001628280-24-026217 · wk-form4_1717431411.xml · derivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-29 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:16 UTC |
SATO VICKI LDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026217 · wk-form4_1717431411.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,323,351 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:17 UTC |
SCANGOS GEORGE ADirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001628280-24-026219 · wk-form4_1717431464.xml · derivative · entry 6 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-29 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:17 UTC |
SCANGOS GEORGE ADirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026219 · wk-form4_1717431464.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,989 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:14 UTC |
NELSEN ROBERTDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001628280-24-026213 · wk-form4_1717431281.xml · derivative · entry 5 NELSEN ROBERT · CIK 0001219042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-29 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:14 UTC |
NELSEN ROBERTDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026213 · wk-form4_1717431281.xml · nonDerivative · entry 1 NELSEN ROBERT · CIK 0001219042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 584,148 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:13 UTC |
Napolitano JanetDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001628280-24-026211 · wk-form4_1717431213.xml · derivative · entry 2 Napolitano Janet · CIK 0001821008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-29 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:13 UTC |
Napolitano JanetDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026211 · wk-form4_1717431213.xml · nonDerivative · entry 1 Napolitano Janet · CIK 0001821008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,806 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:15 UTC |
Ramasastry SairaDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001628280-24-026215 · wk-form4_1717431347.xml · derivative · entry 2 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-29 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:15 UTC |
Ramasastry SairaDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026215 · wk-form4_1717431347.xml · nonDerivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,619 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 15:59 UTC |
Hatfield Jeffrey S.Director
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001628280-24-026193 · wk-form4_1717430363.xml · derivative · entry 2 Hatfield Jeffrey S. · CIK 0001609879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-29 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 15:59 UTC |
Hatfield Jeffrey S.Director
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026193 · wk-form4_1717430363.xml · nonDerivative · entry 1 Hatfield Jeffrey S. · CIK 0001609879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,806 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:08 UTC |
MORE ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001628280-24-026207 · wk-form4_1717430899.xml · derivative · entry 3 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-29 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:08 UTC |
MORE ROBERT JDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026207 · wk-form4_1717430899.xml · nonDerivative · entry 1 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,683 Read SEC document |
| May 29, 2024 Filed May 31, 2024 18:43 UTC |
Farid RamyDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001628280-24-025999 · wk-form4_1717180989.xml · derivative · entry 3 Farid Ramy · CIK 0001797707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-28 F2 · derivative.exercise_date: Shares subject to the stock option vest and become exercisable on the earlier of (i) May 29, 2025, or (i) the date of the Company's next annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 31, 2024 18:43 UTC |
Farid RamyDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001628280-24-025999 · wk-form4_1717180989.xml · derivative · entry 2 Farid Ramy · CIK 0001797707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option vest and become exercisable on May 29, 2025, and the remaining shares vest in 24 equal monthly installments thereafter. Read SEC document |
| May 29, 2024 Filed May 31, 2024 18:43 UTC |
Farid RamyDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-025999 · wk-form4_1717180989.xml · nonDerivative · entry 1 Farid Ramy · CIK 0001797707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Read SEC document |
| May 29, 2024 Filed May 31, 2024 18:40 UTC |
BISCHOFBERGER NORBERT WDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001628280-24-025997 · wk-form4_1717180847.xml · derivative · entry 3 BISCHOFBERGER NORBERT W · CIK 0001190273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-28 F2 · derivative.exercise_date: Shares subject to the stock option vest and become exercisable on the earlier of (i) May 29, 2025, or (i) the date of the Company's next annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 31, 2024 18:40 UTC |
BISCHOFBERGER NORBERT WDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001628280-24-025997 · wk-form4_1717180847.xml · derivative · entry 2 BISCHOFBERGER NORBERT W · CIK 0001190273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option vest and become exercisable on May 29, 2025, and the remaining shares vest in 24 equal monthly installments thereafter. Read SEC document |
| May 29, 2024 Filed May 31, 2024 18:40 UTC |
BISCHOFBERGER NORBERT WDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-025997 · wk-form4_1717180847.xml · nonDerivative · entry 1 BISCHOFBERGER NORBERT W · CIK 0001190273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:14 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
SaleCommon Stock | 72,995 | $9.46 | $690,364.81 |
DisclosureSEC source: 0001628280-24-014878 · wk-form4_1712261678.xml · nonDerivative · entry 1 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 678,457 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:58 UTC |
HANLY ANN M.EVP & Chief Technology Officer
|
SaleCommon Stock | 2,711 | $10.05 | $27,250.97 |
DisclosureSEC source: 0001628280-24-014468 · wk-form4_1712105892.xml · nonDerivative · entry 1 HANLY ANN M. · CIK 0001854528 · EVP & Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,069 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| March 27, 2024 Filed Mar 28, 2024 16:18 UTC |
Lee SungEVP & Chief Financial Officer
|
SaleCommon Stock | 6,008 | $9.89 | $59,404.10 |
DisclosureSEC source: 0001628280-24-013555 · wk-form4_1711642726.xml · nonDerivative · entry 1 Lee Sung · CIK 0001793200 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,492 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 00:30 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 17,722 | $11.65 | $206,521.55 |
DisclosureSEC source: 0001628280-24-006980 · wk-form4_1708993836.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,989 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 20, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.21 to $11.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 00:32 UTC |
Lee SungEVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $10.11 | $0.00 |
DisclosureSEC source: 0001628280-24-006983 · wk-form4_1708993922.xml · derivative · entry 2 Lee Sung · CIK 0001793200 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2034-02-21 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 00:32 UTC |
Lee SungEVP & Chief Financial Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-006983 · wk-form4_1708993922.xml · nonDerivative · entry 1 Lee Sung · CIK 0001793200 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,500 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 19:34 UTC |
HANLY ANN M.EVP & Chief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $10.11 | $0.00 |
DisclosureSEC source: 0001628280-24-006985 · wk-form4_1708994010.xml · derivative · entry 4 HANLY ANN M. · CIK 0001854528 · EVP & Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2034-02-21 F4 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter. F4 · ownership.direct: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 19:34 UTC |
HANLY ANN M.EVP & Chief Technology Officer
|
SaleCommon Stock | 12,296 | $10.05 | $123,520.70 |
DisclosureSEC source: 0001628280-24-006985 · wk-form4_1708994010.xml · nonDerivative · entry 2 HANLY ANN M. · CIK 0001854528 · EVP & Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,780 F2 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 19:34 UTC |
HANLY ANN M.EVP & Chief Technology Officer
|
GrantCommon Stock | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-006985 · wk-form4_1708994010.xml · nonDerivative · entry 1 HANLY ANN M. · CIK 0001854528 · EVP & Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,076 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 00:32 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $10.11 | $0.00 |
DisclosureSEC source: 0001628280-24-006984 · wk-form4_1708993962.xml · derivative · entry 2 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2034-02-21 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 00:32 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
GrantCommon Stock | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-006984 · wk-form4_1708993962.xml · nonDerivative · entry 1 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 751,452 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 00:31 UTC |
Pang PhillipEVP & Chief Medical Officer
|
SaleCommon Stock | 14,568 | $10.05 | $146,344.30 |
DisclosureSEC source: 0001628280-24-006982 · wk-form4_1708993886.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,111 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 00:30 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 10,028 | $10.05 | $100,737.28 |
DisclosureSEC source: 0001628280-24-006980 · wk-form4_1708993836.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,711 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 02:02 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 16,872 | $10.22 | $172,384.60 |
DisclosureSEC source: 0001628280-24-005747 · wk-form4_1708480944.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,739 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 20, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.07 to $10.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 23:56 UTC |
Pang PhillipEVP & Chief Medical Officer
|
SaleCommon Stock | 3,321 | $10.24 | $34,005.71 |
DisclosureSEC source: 0001628280-24-005418 · wk-form4_1708127793.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,679 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 02:02 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 10,878 | $10.24 | $111,386.37 |
DisclosureSEC source: 0001628280-24-005747 · wk-form4_1708480944.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,611 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 19:47 UTC |
Pang PhillipEVP & Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,591 | $1.53 Strike: $1.53 | $72,814.23 |
DisclosureSEC source: 0001628280-24-000169 · wk-form4_1704311270.xml · derivative · entry 6 Pang Phillip · CIK 0001787370 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,591 shares Expires 2028-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vested in 36 equal monthly installments thereafter. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 19:47 UTC |
Pang PhillipEVP & Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,576 | $1.58 Strike: $1.58 | $21,382.20 |
DisclosureSEC source: 0001628280-24-000169 · wk-form4_1704311270.xml · derivative · entry 5 Pang Phillip · CIK 0001787370 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,576 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vested in 36 equal monthly installments thereafter. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 19:47 UTC |
Pang PhillipEVP & Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,833 | $0.86 Strike: $0.86 | $16,102.22 |
DisclosureSEC source: 0001628280-24-000169 · wk-form4_1704311270.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,833 shares Expires 2027-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vested in 36 equal monthly installments thereafter. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 19:47 UTC |
Pang PhillipEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 47,591 | $1.53 | $72,814.23 |
DisclosureSEC source: 0001628280-24-000169 · wk-form4_1704311270.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 19:47 UTC |
Pang PhillipEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 13,576 | $1.58 | $21,382.20 |
DisclosureSEC source: 0001628280-24-000169 · wk-form4_1704311270.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 19:47 UTC |
Pang PhillipEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 18,833 | $0.86 | $16,102.22 |
DisclosureSEC source: 0001628280-24-000169 · wk-form4_1704311270.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2023 Filed Oct 20, 2023 18:15 UTC |
MORE ROBERT JDirector
|
OtherCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-034785 · wk-form4_1697825747.xml · nonDerivative · entry 2 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 495,890 F2 · shares: Shares transferred for no consideration to APNG 1 upon vesting of an RSU award held by the Reporting Person for the benefit of APNG 1. F3 · ownership.nature: The shares are held by APNG 1. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG I. The Reporting Person may be deemed to beneficially own the shares held by APNG 1, and disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| October 19, 2023 Filed Oct 20, 2023 18:15 UTC |
MORE ROBERT JDirector
|
OtherCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-034785 · wk-form4_1697825747.xml · nonDerivative · entry 1 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,683 F1 · kind: Shares held by the Reporting Person for the benefit of Alta Partners NextGen Fund I, L.P. (APNG 1) were transferred for no consideration to APNG 1 in connection with the vesting of an RSU award. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG 1. As such, the Reporting Person may be deemed to beneficially own the shares held by APNG 1. However, the Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. F1 · shares: Shares held by the Reporting Person for the benefit of Alta Partners NextGen Fund I, L.P. (APNG 1) were transferred for no consideration to APNG 1 in connection with the vesting of an RSU award. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG 1. As such, the Reporting Person may be deemed to beneficially own the shares held by APNG 1. However, the Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| October 17, 2023 Filed Oct 18, 2023 18:14 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 1,750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-034571 · wk-form4_1697652863.xml · nonDerivative · entry 4 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,750,000 F1 · kind: Transfer without consideration for tax planning purposes. F4 · ownership.nature: The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees. Read SEC document |
| October 17, 2023 Filed Oct 18, 2023 18:14 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 1,750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-034571 · wk-form4_1697652863.xml · nonDerivative · entry 3 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Transfer without consideration for tax planning purposes. F3 · ownership.nature: The shares are held by the spouse of the reporting person. Read SEC document |
| October 17, 2023 Filed Oct 18, 2023 18:14 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 1,750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-034571 · wk-form4_1697652863.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,750,000 F1 · kind: Transfer without consideration for tax planning purposes. F2 · ownership.nature: The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees. Read SEC document |
| October 17, 2023 Filed Oct 18, 2023 18:14 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 1,750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-034571 · wk-form4_1697652863.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,489 F1 · kind: Transfer without consideration for tax planning purposes. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 19:54 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 827,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049722 · doc4.xml · nonDerivative · entry 7 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Transfer without consideration for tax planning purposes. F7 · ownership.nature: The shares are held in the name of the Katherine Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 19:54 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 111,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049722 · doc4.xml · nonDerivative · entry 6 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Transfer without consideration for tax planning purposes. F6 · ownership.nature: The shares are held in the name of the Katherine Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.